Managed marketplaces and reality TV: How a new generation of gatekeepers is opening biotech up to amateur investors

"The average person will never get the chance to invest in a future unicorn like Moderna: The type of private equity deals that brought the now-famous biotech to the world are done in country clubs and coffee houses in a select few places, leaving anyone who is not a hedge fund manager, venture capitalist or disgustingly rich individual out of the game."

“Historically, only professional investors, high net worth individuals or accredited investors could legally invest in private companies,” said Neil Littman, founder, CEO and general partner at Bioverge, an investment platform that connects individual investors with healthcare startups."

Read the full article in Fierce Biotech.